Description

Somazina (citicoline) solution for injections 1000 mg/4 ml. ampoules №10

Ingredients

Each ampoule contains 1000 mg of citicoline.

Dosage

The usual dosage is 1000 mg (1 ampoule) per day, administered via intramuscular or intravenous injection.

Indications

Somazina injections are indicated for the treatment of neurological disorders such as stroke, traumatic brain injury, and cognitive disorders.

Contraindications

Do not use Somazina injections in patients with hypersensitivity to citicoline or any other component of the formulation.

Directions

Administer the injection as directed by a healthcare professional. Do not exceed the recommended dosage.

Scientific Evidence

Citicoline, the active ingredient in Somazina injections, has been extensively studied for its neuroprotective and cognitive-enhancing effects. Research has shown that citicoline can improve cognitive function, enhance memory, and support brain health.

Studies have demonstrated the efficacy of citicoline in improving outcomes in patients with neurological conditions such as stroke and traumatic brain injury. Citicoline works by increasing levels of neurotransmitters, promoting neuroplasticity, and protecting brain cells from damage.

Additional Information

Somazina injections are well-tolerated, with minimal side effects reported. However, it is important to consult a healthcare provider before starting treatment, especially if you have any underlying medical conditions or are taking other medications.

Overall, Somazina (citicoline) solution for injections 1000 mg/4 ml. ampoules №10 is a valuable therapeutic option for patients with neurological disorders, backed by scientific evidence supporting its efficacy in improving cognitive function and neuroprotection.